[go: up one dir, main page]

ID30504A - Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan - Google Patents

Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan

Info

Publication number
ID30504A
ID30504A IDW00200101649A ID20011649A ID30504A ID 30504 A ID30504 A ID 30504A ID W00200101649 A IDW00200101649 A ID W00200101649A ID 20011649 A ID20011649 A ID 20011649A ID 30504 A ID30504 A ID 30504A
Authority
ID
Indonesia
Prior art keywords
spontantly
benzoil
staurosporin
dispersed
composition
Prior art date
Application number
IDW00200101649A
Other languages
English (en)
Inventor
Graham Matthews
Barbara Haberlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10847896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30504(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID30504A publication Critical patent/ID30504A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW00200101649A 1999-02-16 2000-02-14 Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan ID30504A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903547.9A GB9903547D0 (en) 1999-02-16 1999-02-16 Organic compounds

Publications (1)

Publication Number Publication Date
ID30504A true ID30504A (id) 2001-12-13

Family

ID=10847896

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101649A ID30504A (id) 1999-02-16 2000-02-14 Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan

Country Status (34)

Country Link
US (3) US20020061873A1 (id)
EP (1) EP1152750B1 (id)
JP (2) JP5057610B2 (id)
KR (2) KR100880859B1 (id)
CN (1) CN100367930C (id)
AR (2) AR022589A1 (id)
AT (1) ATE430554T1 (id)
AU (1) AU765776B2 (id)
BR (1) BRPI0008228B8 (id)
CA (1) CA2362277C (id)
CL (1) CL2009001682A1 (id)
CZ (1) CZ303979B6 (id)
DE (1) DE60042151D1 (id)
DK (1) DK1152750T3 (id)
EC (1) ECSP083351A (id)
ES (1) ES2326783T3 (id)
GB (1) GB9903547D0 (id)
HK (1) HK1045807B (id)
HU (1) HUP0105364A3 (id)
ID (1) ID30504A (id)
IL (3) IL144512A0 (id)
MY (1) MY128362A (id)
NO (1) NO331232B1 (id)
NZ (1) NZ513529A (id)
PE (1) PE20001499A1 (id)
PL (1) PL198330B1 (id)
PT (1) PT1152750E (id)
RU (1) RU2266121C2 (id)
SI (1) SI1152750T1 (id)
SK (1) SK286967B6 (id)
TR (1) TR200102385T2 (id)
TW (1) TWI240636B (id)
WO (1) WO2000048571A1 (id)
ZA (1) ZA200106677B (id)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
EP1372611B1 (en) * 2001-03-26 2006-05-17 Novartis AG Pharmaceutical composition comprising a poorly water-soluble staurosporine, a surfactant and a water-soluble polymer
US20040167134A1 (en) 2001-05-16 2004-08-26 Christian Bruns Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
KR100926194B1 (ko) * 2001-10-30 2009-11-09 노파르티스 아게 Ｆｌｔ３ 수용체 티로신 키나아제 활성의 억제제로서의스타우로스포린 유도체
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
BR0312817A (pt) * 2002-07-23 2005-04-19 Novartis Ag Composição de pomada oftálmica compreendendo uma droga, uma base de pomada e um agente solubilizante/dispersante
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
GB0419159D0 (en) * 2004-08-27 2004-09-29 Novartis Ag Organic compounds
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
RU2454220C2 (ru) 2006-08-16 2012-06-27 Новартис Аг Способ получения твердых дисперсий высококристаллических терапевтических соединений
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
US20090155352A1 (en) * 2007-11-20 2009-06-18 Cephalon, Inc. Microemulsion containing indolocarbazole compound and dosage forms containing the same
EP2229936B1 (en) * 2009-03-09 2015-05-06 PharmaSol GmbH Nanonized testosterone formulations for improved bioavailability
WO2011000811A2 (en) * 2009-06-30 2011-01-06 Novartis Ag Organic compounds
CN102781425B (zh) * 2009-12-22 2014-08-13 利奥制药有限公司 含有维生素d类似物以及溶剂和表面活性剂混合物的皮肤用组合物
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US9387446B2 (en) 2011-09-22 2016-07-12 Ariel-University Research And Development Company Ltd. Emulsions and methods of making emulsions
KR20190032265A (ko) * 2015-12-09 2019-03-27 포스파제닉스 리미티드 약제학적 제형
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
IL267006B2 (en) 2016-12-21 2024-11-01 Phosphagenics Ltd Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof
EP4058465A1 (en) 2019-11-14 2022-09-21 Cohbar Inc. Cxcr4 antagonist peptides

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4735939A (en) 1987-02-27 1988-04-05 The Dow Chemical Company Insecticidal activity of staurosporine
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
DE3824034C1 (id) * 1988-07-15 1989-09-14 Gustav 7290 Freudenstadt De Memminger
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
JPH06507172A (ja) 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US6306421B1 (en) * 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5639474A (en) 1993-07-01 1997-06-17 Hanmi Pharm. Ind., Ltd. Cyclosporin soft capsule composition
ATE317397T1 (de) 1993-11-17 2006-02-15 Athena Neurosciences Inc Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
GB9325395D0 (en) * 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
AU1911095A (en) 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
WO1995032975A1 (en) * 1994-06-01 1995-12-07 Ciba-Geigy Ag Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
GB2308545B (en) 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733358A3 (de) * 1995-03-21 1998-05-20 Novartis AG Intravenös applizierbare Nanosuspensionen
WO1998013032A1 (en) 1996-09-27 1998-04-02 Trega Biosciences, Inc. Compositions of therapeutic agents suitable for oral administration
DE19641672A1 (de) 1996-10-10 1998-04-16 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen
US5827522A (en) 1996-10-30 1998-10-27 Troy Corporation Microemulsion and method
NZ314060A (en) 1997-01-13 1997-08-22 Bernard Charles Sherman Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s)
AU737053B2 (en) * 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
AU728698B2 (en) 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
KR100509130B1 (ko) 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 친지성 화합물의 자가유화 제제
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
GB9814527D0 (en) * 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
AR013276A1 (es) 1998-07-31 2000-12-13 Panacea Biotec Ltd Composicion de ciclosporina transparente
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0105364A3 (en) 2003-02-28
NO20013964D0 (no) 2001-08-15
AR082579A2 (es) 2012-12-19
BR0008228A (pt) 2001-10-30
PT1152750E (pt) 2009-08-07
EP1152750B1 (en) 2009-05-06
KR20080064914A (ko) 2008-07-09
KR100880859B1 (ko) 2009-01-30
BRPI0008228B8 (pt) 2021-05-25
EP1152750A1 (en) 2001-11-14
CA2362277A1 (en) 2000-08-24
JP5057610B2 (ja) 2012-10-24
AR022589A1 (es) 2002-09-04
CA2362277C (en) 2010-03-30
TWI240636B (en) 2005-10-01
BRPI0008228B1 (pt) 2016-08-23
DK1152750T3 (da) 2009-08-24
JP2012111763A (ja) 2012-06-14
IL144512A (en) 2011-03-31
CN1339963A (zh) 2002-03-13
SI1152750T1 (sl) 2009-10-31
RU2266121C2 (ru) 2005-12-20
NO331232B1 (no) 2011-11-07
AU765776B2 (en) 2003-10-02
US20080070897A1 (en) 2008-03-20
CN100367930C (zh) 2008-02-13
US20020061873A1 (en) 2002-05-23
TR200102385T2 (tr) 2002-09-23
PL198330B1 (pl) 2008-06-30
US20140056974A1 (en) 2014-02-27
IL192666A0 (en) 2009-02-11
HUP0105364A2 (hu) 2002-05-29
NO20013964L (no) 2001-10-15
MY128362A (en) 2007-01-31
AU3154200A (en) 2000-09-04
US8575147B2 (en) 2013-11-05
US8722664B2 (en) 2014-05-13
NZ513529A (en) 2003-10-31
PE20001499A1 (es) 2001-01-12
WO2000048571A1 (en) 2000-08-24
HK1045807A1 (zh) 2002-12-13
CZ303979B6 (cs) 2013-07-31
ES2326783T3 (es) 2009-10-20
HK1045807B (zh) 2008-12-05
ECSP083351A (es) 2008-08-29
CZ20012931A3 (cs) 2001-11-14
SK286967B6 (sk) 2009-08-06
ZA200106677B (en) 2003-01-14
SK11722001A3 (sk) 2001-12-03
ATE430554T1 (de) 2009-05-15
CL2009001682A1 (es) 2010-07-23
DE60042151D1 (de) 2009-06-18
GB9903547D0 (en) 1999-04-07
PL350556A1 (en) 2002-12-16
IL144512A0 (en) 2002-05-23
JP2002537242A (ja) 2002-11-05
KR20010093281A (ko) 2001-10-27

Similar Documents

Publication Publication Date Title
ID30504A (id) Komposisi-benzoil staurosporin yang dapat terdispersi secara spontan
NO20021116D0 (no) Ny sammensetning
DE60002795D1 (de) Bindermittelzusammensetzung
DE60027505D1 (de) Schleifmittelzusammensetzung
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
AR023440A1 (es) Composiciones antitranspirantes
DE60014907D1 (de) Schleifmittelzusammensetzung
ID29430A (id) Komposisi herbisida
EE200100420A (et) Kütusekoostis
DE60014179D1 (de) Tintenzusammensetzungen
NO20021115L (no) Ny sammensetning
ID29785A (id) Komposisi-komposisi sampo
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE60118381D1 (de) Primerzusammensetzung
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
DK199901730A (da) Ny Sammensætning
FR2791258B1 (fr) Composition amincissante
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ID26295A (id) Komposisi keras-ultraviolet
ID27329A (id) Komposisi penghambat
ID26485A (id) Komposisi paroksetina